| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |